TUMME
DEAD

Serial Number

79355169

Owner

Tumme IBS Healthcare Pty Ltd

Attorney

Kenneth F. Florek

Filing Date

Oct 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TUMME Trademark

Serial Number: 79355169

TUMME is a trademark filed by Tumme IBS Healthcare Pty Ltd on October 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Tumme IBS Healthcare Pty Ltd (3 trademarks)

Suite 7, 400 Canterbury Road

Entity Type: 99

Trademark Details

Filing Date

October 4, 2022

Registration Date

Not Registered

Goods & Services

Dietetic food supplements; food supplements for medical purposes; medicated food supplements; mineral food supplements; nutritional supplements; nutritional supplements for medical use; probiotic bacterial formulations for medical use, namely, probiotic dietary food supplements for the management of irritable bowel syndrome (IBS) symptoms; collagen-based medicated food supplements; vitamin supplements; vitamin tablets; vitamins; dietetic preparations adapted for medical use; homeopathic medicines for the management of irritable bowel syndrome (IBS) symptoms; homeopathic pharmaceuticals for the management of irritable bowel syndrome (IBS) symptoms; homeopathic supplements; pharmaceutical compositions, namely, pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms; pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms; pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms for health care; medicines for the management of irritable bowel syndrome (IBS) symptoms for human use; medicinal preparations for the management of irritable bowel syndrome (IBS) symptoms; medicinal food supplements; pastilles for pharmaceutical purposes, namely, medicated confectionery; pharmaceutical sweets, namely, medicated confectionery; herbal dietary supplements; dietary food supplements; protein dietary supplements; yeast dietary supplements; antioxidant food supplements; enzyme dietary supplements; plant extracts for pharmaceutical use, namely, herbal food supplements; dietary supplements; pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms; pharmaceutical products for the management of irritable bowel syndrome (IBS) symptoms

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Sep 3, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 3, 2025 FICR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 3, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 3, 2024 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 7, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 17, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 20, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 20, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 20, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 12, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 18, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 22, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 21, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 19, 2023 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 4, 2023 ADCH
APPLICATION FILING RECEIPT MAILED
Nov 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 17, 2022 REPR